The DOI matches its Crossref record; 331 of the 331 references it cites were found in a registry or an index.
Nanotechnology: Intelligent Design to Treat Complex Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–331 of 331
Nanorobotics Control Design: A Collective Behavior Approach for Medicine
Cavalcanti, A., & Freitas, R. A. (2005) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2005.850469 · Cited by 116
Antimicrobial susceptibility of Enterobacteriaceae isolated from vegetables
Österblad, M., Pensala, O., Peterzens, M., Heleniusc, H., & Huovinen, P. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.4.503 · Cited by 113
Targeting Hyperthermia for Renal Cell Carcinoma Using Human MN Antigenspecific Magnetoliposomes
Shinkai, M., Biao, L., Honda, H., Yoshikawa, K., Shimizu, K., Saga, S., Wakabayashi, T., Yoshida, J., & Kobayashi, T. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01070.x · Cited by 111
Immunostimulation Mechanism of LPD Nanoparticle as a Vaccine Carrier
Cui, Z., Han, S., Vangasseri, D. P., & Huang, L. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049907k · Cited by 111
Effective intracellular delivery of oligonucleotides in order to make sense of antisense
Shi, F., & Hoekstra, D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.016 · Cited by 111
Calcitonin Therapy in Osteoporosis
Muñoz‐Torres, M., Alonso, G., & Raya, P. M. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403020-00006 · Cited by 110
Ferrero, J.-M., Weber, B. E., Geay, J.-F., Lepille, D., Orfeuvre, H., Combe, M., Mayer, F., Leduc, B., Bourgeois, H. P., Paraiso, D., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl376 · Cited by 110
Collins, D. S., Litzinger, D. C., & Huang, L. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90102-t · Cited by 109
Mosqueira, V. C. F., Loiseau, P. M., Bories, C., Legrand, P., Devissaguet, J., & BARRATT, G. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1222-1228.2004 · Cited by 109
Kono, K., Zenitani, K.-I., & Takagishi, T. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90325-5 · Cited by 108
Debin, A., Kravtzoff, R., Santiago, J. V., Cazales, L., Spérandio, S., Melber, K., Janowicz, Z. A., Betbeder, D., & Moynier, M. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00191-3 · Cited by 108
Kreuter, J., Täuber, U., & Illi, V. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600681129 · Cited by 108
Cui, Z. (2005) · Advances in genetics · doi:10.1016/s0065-2660(05)54011-2 · Cited by 108
Mucosal adjuvants and delivery systems for protein‐, DNA‐ and RNA‐based vaccines
Vajdy, M., Srivastava, I. K., Polo, J., Donnelly, J., O’Hagan, D. T., & Singh, M. (2004) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2004.01288.x · Cited by 105
Visible-Light-Stimulated Destabilization of PEG-Liposomes
Mueller, A., Bondurant, B., & O’Brien, D. F. (2000) · Macromolecules · doi:10.1021/ma000055l · Cited by 104
Owais, M., Varshney, G. C., Choudhury, A., Chandra, S., & Gupta, C. M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.180 · Cited by 104
Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release
Kunisawa, J., Masuda, T., Katayama, K., Yoshikawa, T., Tsutsumi, Y. M., Akashi, M., Mayumi, T., & Nakagawa, S. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.020 · Cited by 102
A novel gene delivery system using EGF receptor‐mediated endocytosis
Chen, J., Gamou, S., Takayanagi, A., & Shimizu, N. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80357-9 · Cited by 101
Selective cell killing by microparticle absorption of pulsed laser radiation
Lin, C. P., Kelly, M. W., Sibayan, S. A. B., Latina, M. A., & Anderson, R. R. (1999) · IEEE Journal of Selected Topics in Quantum Electronics · doi:10.1109/2944.796318 · Cited by 100
Ward, C. M., Pechar, M., Oupický, D., Ulbrich, K., & Seymour, L. W. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.296 · Cited by 100
pH-sensitive, plasma-stable liposomes with relatively prolonged residence in circulation
Liu, D., & Huang, L. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90284-u · Cited by 99
Fresta, M., Fontana, G., Bucolo, C., Cavallaro, G., Giammona, G., & Puglisi, G. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200103)90:3<288::aid-jps4>3.0.co;2-5 · Cited by 99
Intravitreal delivery of oligonucleotides by sterically stabilized liposomes.
Bochot, A., Fattal, E., Boutet, V., Deverre, J. R., Jeanny, J., Chacun, H., & Couvreur, P. (2002) · PubMed · Cited by 98
Self-citationNew drugs and treatment for respiratory syncytial virus
Maggon, K., & Barik, S. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.423 · Cited by 97
Thierry, A. R., Rahman, A., & Dritschilo, A. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1142 · Cited by 96
Synthetic Vaccines: The Role of Adjuvants in Immune Targeting
Jiang, Z., & Koganty, R. R. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457340 · Cited by 94
Virosomal adjuvanted antigen delivery systems
Moser, C., Metcalfe, I. C., & Viret, J. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.189 · Cited by 94
Jaeghere, F. D., Allémann, É., Kubel, F., Galli, B., Cozens, R. M., Doelker, É., & Gurny, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00272-8 · Cited by 94
Intravitreal administration of antisense oligonucleotides: potential of liposomal delivery
Bochot, A., Couvreur, P., & Fattal, E. (2000) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(99)00014-2 · Cited by 93
Self-citationOral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles
Ubrich, N., Schmidt, C., Bodmeier, R. A., Hoffman, M., & Maincent, P. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.09.019 · Cited by 91
Anzai, Y., McLachlan, S. J., Morris, M., Saxton, R. E., & Lufkin, R. B. (1994) · PubMed Central · Cited by 91
Polymer based pH-sensitive carriers as a means to improve the cytoplasmic delivery of drugs
Roux, E., Francis, M. F., Winnik, F. M., & Leroux, J. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00183-7 · Cited by 90
Formulation and Evaluation of a Folic Acid Receptor-Targeted Oral Vancomycin Liposomal Dosage Form
Anderson, K. E., Eliot, L., Stevenson, B. R., & Rogers, J. A. (2001) · Pharmaceutical Research · doi:10.1023/a:1011002913601 · Cited by 88
Bucolo, C., Maltese, A., Puglisi, G., & Pignatello, R. (2002) · Ophthalmic Research · doi:10.1159/000065608 · Cited by 88
Vincent, L., Varet, J., Pille, J., Bompais, H., Opolon, P., Maksimenko, A., Malvy, C., Mirshahi, M., Lu, H., Vannier, J., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11105 · Cited by 88
The diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide
Weissleder, R., Elizondo, G., Stark, D. D., Hahn, P. F., Marfil, J., Gonzalez, J., Saini, S., Todd, L., & Ferrucci, J. T. (1989) · American Journal of Roentgenology · doi:10.2214/ajr.152.1.175 · Cited by 86
Approaches to Enhance the Efficacy of DNA Vaccines
Manoj, S., Babiuk, L. A., & den Hurk, S. V. D. L. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490269251 · Cited by 86
Davis, S., & Szoka, F. C. (1998) · Bioconjugate Chemistry · doi:10.1021/bc980047y · Cited by 85
Clinical relevance of the molecular mechanisms of resistance to anti-cancer drugs
Brown, R. E., & Links, M. J. (1999) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399499001099x · Cited by 85
Anti-JL1 antibody-conjugated poly (l-lysine) for targeted gene delivery to leukemia T cells
Suh, W., Chung, J.-K., Park, S.-H., & Kim, S. W. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00273-5 · Cited by 84
The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer
Değim, Z., Ünal, N., Eşsiz, D., & Abbasoğlu, U. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.05.027 · Cited by 84
Folate receptor targeted delivery of liposomal daunorubicin into tumor cells.
Ni, S., Stephenson, S. M., & Lee, R. J. (2002) · PubMed · Cited by 83
In vitro degradation of insulin-loaded poly (n-butylcyanoacrylate) nanoparticles
Sullivan, C. O., & Birkinshaw, C. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.11.001 · Cited by 82
Chang, T. M. S., Powanda, D., & Yu, W. P. (2003) · Artificial Cells Blood Substitutes and Biotechnology · doi:10.1081/bio-120023155 · Cited by 82
Wang, J., Hu, B., Xu, M., Yan, Q., Liu, S., Zhu, X., Sun, Z., Tao, D., Ding, L., Reed, E., et al. (2006) · PubMed · Cited by 81
Arnedo, A., Irache, J. M., Merodio, M., & Espuelas, S. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.10.009 · Cited by 80
Lind, K., Kresse, M., Debus, N., & Müller, R. H. (2002) · Journal of drug targeting · doi:10.1080/10611860290022651 · Cited by 80
Pulmonary DNA vaccination: Concepts, possibilities and perspectives
Bivas‐Benita, M., Ottenhoff, T. H. M., Junginger, H. E., & Borchard, G. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.028 · Cited by 79
Soma, C. E., Dubernet, C., BARRATT, G. M., Némati, F., Appel, M., Benita, S., & Couvreur, P. (1999) · Pharmaceutical Research · doi:10.1023/a:1018902031370 · Cited by 78
Self-citationConley, J., Yang, H., Wilson, T., Blasetti, K. L., Dininno, V., Schnell, G., & Wong, J. P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1288 · Cited by 76
Pinto‐Alphandary, H., Aboubakar, M., Jaillard, D., Couvreur, P., & Vauthier, C. (2003) · Pharmaceutical Research · doi:10.1023/a:1024470508758 · Cited by 75
Self-citationYoussef, M. T., Fattal, E., Alonso, M. J., Roblot-Treupel, L., Sauzieres, J., Tancrède, C., Omnès, A., Couvreur, P., & Andremont, A. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.8.1204 · Cited by 74
Self-citationGao, H., & Hui, K. M. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301471 · Cited by 74
Shi, F., Rakhmilevich, A. L., Heise, C. P., Oshikawa, K., Sondel, P. M., Yang, N.-S., & Mahvi, D. M. (2002) · PubMed · Cited by 73
Fielding, R. M., Lewis, R. O., & Moon-McDermott, L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011925132473 · Cited by 72
New technology platforms in the development of vaccines for the future
Glück, R., & Metcalfe, I. C. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00513-3 · Cited by 72
Ibuprofen-loaded nanoparticles prepared by a co-precipitation method and their release properties
Jiang, B., Hu, L., Gao, C., & Shen, J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.08.008 · Cited by 72
Macrophage Specific Drug Delivery in Experimental Leishmaniasis
Basu, M. K., & Lala, S. (2004) · Current Molecular Medicine · doi:10.2174/1566524043360186 · Cited by 71
Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin
Mann, J. F. S., Ferro, V. A., Mullen, A. B., Tetley, L., Mullen, M., Carter, K. C., Alexander, J. K., & STIMSON, W. H. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.11.067 · Cited by 71
Tyagi, R., Lala, S., Verma, A. K., Nandy, A. K., Mahato, S. B., Maitra, A., & Basu, M. K. (2005) · Journal of drug targeting · doi:10.1080/10611860500046732 · Cited by 70
Insulin‐loaded nanocapsules for oral administration: In vitro and in vivo investigation
Aboubakar, M., Couvreur, P., Pinto‐Alphandary, H., Gouritin, B., Lacour, B., Farinotti, R., Puisieux, F., & Vauthier, C. (2000) · Drug Development Research · doi:10.1002/(sici)1098-2299(200002)49:2<109::aid-ddr4>3.0.co;2-# · Cited by 70
Self-citationEspuelas, S. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg351 · Cited by 70
Drug and gene targeting to the brain via blood–brain barrier receptor-mediated transport systems
Pardridge, W. M. (2005) · International Congress Series · doi:10.1016/j.ics.2005.02.011 · Cited by 69
Dembri, A., Montisci, M., Gantier, J.-C., Chacun, H., & Ponchel, G. (2001) · Pharmaceutical Research · doi:10.1023/a:1011050209986 · Cited by 68
Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C
Hügle, T., & Cerny, A. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.397 · Cited by 68
Pain and the blood–brain barrier: obstacles to drug delivery
Wolka, A. M., Huber, J. D., & Davis, T. P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00100-5 · Cited by 68
Design and characterisation of new nanoparticulate polymer blends for drug delivery
Csaba, N., Gonzalez, L., Sánchez, A., & Alonso, M. J. (2004) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/1568562041753098 · Cited by 67
Bakker‐Woudenberg, I. A. J. M. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00021-3 · Cited by 66
The pathway to commercialization for nanomedicine
Flynn, T., & Wei, C. (2005) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2004.11.010 · Cited by 65
Prolongation of Corneal Allograft Survival with Liposome-encapsulated Cyclosporine in the Rat Eye
Milani, J. K., Pleyer, U., Dukes, A. J., et al. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31558-7 · Cited by 65
Gaspar, R. S., Véronique Préat, A., Opperdoes, F. R., & Roland, M. (1992) · Pharmaceutical Research · doi:10.1023/a:1015807706530 · Cited by 64
Watnasirichaikul, S., Rades, T., Tucker, I. G., & Davies, N. M. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778736 · Cited by 64
Liposomal amphotericin B: clinical experience and perspectives
Gibbs, W. J., Drew, R. H., & Perfect, J. R. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.2.167 · Cited by 62
Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers
Opanasopit, P., Sakai, M., Nishikawa, M., Kawakami, S., Yamashita, F., & Hashida, M. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00006-8 · Cited by 61
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis
Murray, H. W. (2004) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2.2.279 · Cited by 61
Guterres, S. S., Fessi, H., BARRATT, G. M., Puisieux, F., & Devissaguet, J. (1995) · Pharmaceutical Research · doi:10.1023/a:1016208125979 · Cited by 60
Biovector™ Nanoparticles Improve Antinociceptive Efficacy of Nasal Morphine
Betbeder, D., Spérandio, S., Latapie, J.-P., Nadaï, J. D., Etienne, A., Zajac, J., & Francès, B. (2000) · Pharmaceutical Research · doi:10.1023/a:1007594602449 · Cited by 60
Nanoparticles as Adjuvants for Vaccines
Kreuter, J. (1995) · Pharmaceutical biotechnology · doi:10.1007/978-1-4615-1823-5_19 · Cited by 58
Synthetic biomimetic supra molecular Biovector™ (SMBV™) particles for nasal vaccine delivery
von Hoegen, P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00175-2 · Cited by 58
Early appearance of in vivo insulin resistance in adult streptozotocin-injected rats.
Blondel, O., & Portha, B. (1989) · PubMed · Cited by 56
Liposomes for oral administration of drugs.
Woodley, J. F. (1985) · PubMed · Cited by 56
Koning, G. A., Morselt, H. W. M., Gorter, A., Allen, T. M., Zalipsky, S., Scherphof, G. L., & Kamps, J. A. A. M. (2003) · Pharmaceutical Research · doi:10.1023/a:1025009300562 · Cited by 56
Magnetic Fluid Hyperthermia (MFH)
Jordan, A., Wust, P., Scholz, R., et al. (1997) · Springer eBooks · doi:10.1007/978-1-4757-6482-6_43 · Cited by 55
Blood Clearance of Dextran Magnetite Particles Determined by a noninvasive in vivo ESR method
Iannone, A., Magin, R. L., Walczak, T., Federico, M., Swartz, H. M., Tomasi, A., & Vannini, V. (1991) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910220251 · Cited by 55
Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens
Fattal, E., Pecquet, S., Couvreur, P., & Andremont, A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00181-3 · Cited by 53
Self-citationElastase activated liposomal delivery to nucleated cells
Pak, C. C., Erukulla, R. K., Ahl, P. L., Janoff, A. S., & Meers, P. R. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00256-9 · Cited by 51
Phase I and pharmacokinetic trial of liposome-encapsulated doxorubicin
Conley, B. A., Egorin, M. J., Whitacre, M. Y., Carter, D. C., Zuhowski, E. G., & Echo, D. A. V. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685327 · Cited by 50
Kamps, J. A. A. M., Koning, G. A., Velinova, M. J., Morselt, H. W. M., Wilkens, M., Gorter, A., Donga, J., & Scherphof, G. L. (2000) · Journal of drug targeting · doi:10.3109/10611860008997902 · Cited by 49
Vitas, A. I., Díaz, R., & Gamazo, C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.1.146 · Cited by 47
Insulin Therapy: Current Alternatives
Gomez-Perez, F. J., & Rull, J. A. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.03.012 · Cited by 46
Erratum to ‘Proniosomes: A Novel Drug Carrier Preparation’
Hu, C., & Rhodes, D. G. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00513-5 · Cited by 46
T-Cell Homing to the Pancreas in Autoimmune Mouse Models of Diabetes: In Vivo MR Imaging
Billotey, C., Aspord, C., Beuf, O., Piaggio, E., Gazeau, F., Janier, M. F., & Thivolet, C. H. (2005) · Radiology · doi:10.1148/radiol.2362040603 · Cited by 46
Sanderson, N. M., & Jones, M. N. (1996) · Journal of drug targeting · doi:10.3109/10611869609015975 · Cited by 45
Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells
Düzgüneş, N., Pretzer, E., Simões, S., Slepushkin, V., Konopka, K., Flasher, D., & de Lima, M. C. P. (1999) · Molecular Membrane Biology · doi:10.1080/096876899294832 · Cited by 45
Fawaz, F., Bonini, F., Guyot, M., Lagueny, A. M., Fessi, H., & Devissaguet, J. (1993) · Pharmaceutical Research · doi:10.1023/a:1018924219540 · Cited by 44
Kubaska, S., Sahani, D. V., Saini, S., et al. (2001) · Clinical Radiology · doi:10.1053/crad.2000.0673 · Cited by 44
Therapeutic vaccination against chronic hepatitis B virus infection
Michel, M., & Bourgine, M. (2005) · Journal of Clinical Virology · doi:10.1016/s1386-6532(05)80019-8 · Cited by 43
Vogel, V., Lochmann, D., Weyermann, J., Mayer, G., Tziatzios, C., van den Broek, J. A., Haase, W., Wouters, D., Schubert, U. S., Kreuter, J., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.11.029 · Cited by 42
Stingl, G., Bröcker, E. ‐., Mertelsmann, R. H., Wolff, K., Schreiber, S. C., Kämpgen, E., Schneeberger, A., Dummer, W., Brennscheid, U., Veelken, H., et al. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.4-551 · Cited by 41
Fielding, R. M., Moon-McDermott, L., Lewis, R. O., & Horner, M. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.503 · Cited by 41
Double Liposomes: Hypoglycemic Effects of Liposomal Insulin on Normal Rats
Katayama, K., Katō, Y., Onishi, H., Nagai, T., & Machida, Y. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120021771 · Cited by 40
Fibrin-Enmeshed Tobramycin Liposomes: Single Application Topical Therapy of Pseudomonas Keratitis
Frucht-Perry, J., Assil, K. K., Ziegler, E. J., Douglas, H., Brown, S. I., Schanzlin, D. J., & Weinreb, R. N. (1992) · Cornea · doi:10.1097/00003226-199209000-00006 · Cited by 39
Schwartz, M. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1015139718466 · Cited by 38
Liposomes as Protein Carriers in Immunology
Leserman, L. (2004) · Journal of Liposome Research · doi:10.1081/lpr-200039198 · Cited by 37
Düzgüneş, N., Simões, S., Slepushkin, V., Pretzer, E., Rossi, J. J., Clercq, E. D., Antao, V., Collins, M. L., & de Lima, M. C. P. (2001) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1081/ncn-100002327 · Cited by 36
Page-Clisson, M.-E., Pinto‐Alphandary, H., Chachaty, É., Couvreur, P., & Andremont, A. (1998) · Pharmaceutical Research · doi:10.1023/a:1011921608964 · Cited by 35
Self-citationLung surfactant as a drug delivery system
Vermehren, C., Frøkjær, S., AURSTAD, T., & HANSEN, J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.029 · Cited by 35
Keyser, J.-L. D., Poupaert, J. H., & Dumont, P. (1991) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600800117 · Cited by 35
Development of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis
Fouarge, M., Dewulft, M., Couvreur, P., Roland, M., & Vranckx, H. (1989) · Journal of Microencapsulation · doi:10.3109/02652048909019899 · Cited by 34
Self-citationCournarie, F., Auchère, D., Chevenne, D., Lacour, B., Seiller, M., & Vauthier, C. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00175-8 · Cited by 33
Self-citationOligonucleotides Targeted Against a Junction Oncogene Are Made Efficient by Nanotechnologies
Maksimenko, A., Malvy, C., Lambert, G., Bertrand, J.-R., Fattal, E., Maccario, J., & Couvreur, P. (2003) · Pharmaceutical Research · doi:10.1023/a:1026122914852 · Cited by 32
Self-citationIn-vivostudies on dexamethasone sodium phosphate liposomes
Al-Muhammed, J., Özer, A. Y., ERCAN, M. T., & Hıncal, A. A. (1996) · Journal of Microencapsulation · doi:10.3109/02652049609026017 · Cited by 32
Simon, M., Wittmar, M., Kissel, T., & Linn, T. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7676-z · Cited by 32
Wang, L., Prakash, R. K., Stein, C. A., Koehn, R. K., & Ruffner, D. E. (2003) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729003768247637 · Cited by 32
Hu, Q., Shew, C. R., Bally, M. B., & Madden, T. D. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00294-2 · Cited by 31
Intellectual property rights in nanotechnology
Bastani, B., & Fernandez, D. (2002) · Thin Solid Films · doi:10.1016/s0040-6090(02)00843-x · Cited by 31
Inhibition of HIV-1 in Cell Culture by Oligonucleotide-Loaded Nanoparticles
Berton, M., Turelli, P., Trono, D., Stein, C. A., Allémann, É., & Gurny, R. (2001) · Pharmaceutical Research · doi:10.1023/a:1010962507273 · Cited by 30
Liposome encapsulation: a method for enhancing the effectiveness of local antibiotics.
Price, C. I., Horton, J. W., & Baxter, C. R. (1994) · PubMed · Cited by 29
Harandi, A. M. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.03.001 · Cited by 28
Emerging techniques in the treatment of postoperative pain
Viscusi, E. R. (2004) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/61.suppl_1.s11 · Cited by 28
Intranasal Immunization against Influenza
Glück, R. (2002) · Journal of Aerosol Medicine · doi:10.1089/089426802320282347 · Cited by 25
Oligonucleotide-based Strategies to Inhibit Human Hepatitis C Virus
Martinand‐Mari, C., Lebleu, B., & Robbins, I. J. (2003) · Oligonucleotides · doi:10.1089/154545703322860834 · Cited by 24
Preclinical and Clinical Experience with a Doxorubicin-Liposome Preparation
Gabizon, A., Amselem, S., Goren, D., et al. (1990) · Journal of Liposome Research · doi:10.3109/08982109009036010 · Cited by 24
New perspectives for cancer chemotherapy by genetic protection of haematopoietic cells
Baum, C., Fairbairn, L., Hildinger, M., Lashford, L. S., Hegewisch-Becker, S., & Rafferty, J. A. (1999) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399499000769 · Cited by 21
Clissold, S. P., Fitton, A., & Chrisp, P. (1991) · Drugs & Aging · doi:10.2165/00002512-199101050-00007 · Cited by 20
Papatheodoridis, G., & Cholongitas, Ε. (2004) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2004.00522.x · Cited by 18
Cellular fate of oligonucleotides when delivered by nanocapsules of poly(isobutylcyanoacrylate)
Toub, N., Angiari, C., Eboué, D., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.03.029 · Cited by 16
Refined tools for the treatment of hepatocellular carcinoma
Sangro, B. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.006 · Cited by 11
Oligonucleotides and Polyribonucleotides: A Review of Antiviral Activity
Markosian, M., & Hyde, R. M. (2005) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020501600202 · Cited by 8
In vivo compatibility and degradation of crosslinked gelatin gels incorporated in knitted Dacron
(2000) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-4636(200007)51:1 · Cited by 4
From Polymer Chemistry and Physicochemistry to Nanoparticulate Drug Carrier Design and Applications
Vauthier, C., Fattal, E., & Labarre, D. (2003) · doi:10.1201/9780203913338-26 · Cited by 4
Self-citation
Cited by
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Metal–Organic Frameworks in Biomedicine
Horcajada, P., Gref, R., Baati, T., Allan, P. K., Maurin, G., Couvreur, P., Férey, G., Morris, R. E., & Serre, C. (2012) · Chemical Reviews · doi:10.1021/cr200256v · Cited by 4,168
Self-citationCellular uptake of nanoparticles: Journey inside the cell
Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M. A., Alkawareek, M. Y., Dreaden, E. C., Brown, D., Alkilany, A. M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00636a · Cited by 2,859
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
Metadata
- Authors
- Couvreur, P., & Vauthier, C.
- Venue
- Pharmaceutical Research
- Published
- 2006-06-21
- Volume
- 23
- Issue
- 7
- Pages
- 1417-1450
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1992865052
- Cited by
- 948
- References
- 331
- FWCI
- 22.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.